Health Condition 1: K00-K95- Diseases of the digestive system
Conditions
Interventions
Intervention1: Ktodex vs ketofol for sedation inercp patients: Group KP(ketofol)will receive1 mg/kg of propofol and 1 mg/kg of ketamine for induction. The patients will receive100 microg/kg/min of pro
Sponsors
Rashi sarna
Eligibility
Inclusion criteria
Inclusion criteria: ï?? 1. ASA I-II 2. Age group of 21-65years 3. Both gender 4. Patients with BMI (25-35 kg/m2) 5. Scheduled to undergo colonoscopy in gastroenterology department
Exclusion criteria
Exclusion criteria: 1.Acute Respiratory tract infections 2.Predicted difficult airway 3.History of allergy to propofol, ketamine or dexmedetomidine 4.Patients on sedatives within two weeks prior tosurgery ï?? 5.Altered mental status (psychiatric and anxiety disorder) ï?? 6.Patients with chronic pain or on painkiller. ï?? 7.Patients with severe hepatic or kidney impairment ï?? 8.Pregnant or breast feeding female
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy of sedation based on intraoperative patient movement scoreTimepoint: The movement score will be seen at T0(baseline), T1 (2.5mins), T2(5mins),T3 (10mins).T4(15mins),T5(20mins),T6(25mins),T7(30mins) | — |
Secondary
| Measure | Time frame |
|---|---|
| ï?¼ 1.Effect on hemodynamics and respiratorydepression ï?¼ 2.Recovery time fromsedation ï?¼ 3.Postoperative Pain Score (Visual AnalogueScore) Timepoint: â?¢ HR, BP, RR, SpO2 will be noted every 5 minutes interval The patients will be observed for 1â??2 hours until the patientâ??s Aldrete score 9 | — |
Countries
India
Contacts
Public ContactRashi Sarna
PGIMER
Outcome results
None listed